Researchers have found in a randomized trial that adding corticosteroid therapy with betamethasone hastened the resolution of ...

As of April 2026, more than 40 million GLP-1 receptor agonist prescriptions are dispensed annually in the United States alone ...

Tens of thousands of Americans are at risk of losing access to HIV treatment as nearly 20 states tighten eligibility rules for AIDS Drug Assistance Programs, known as ADAPs.

Tonsillitis is a common condition predominantly affecting children and adolescents, presenting as acute, recurrent, or chronic infection. This review evaluated the effectiveness of homeopathy for ...

For older women, behavioral therapy (BT) reduces overactive bladder (OAB) symptoms, with greater improvements seen in ...

Depression is a debilitating mental health disorder that is estimated to affect approximately 5% of people worldwide. It is ...

Regulatory milestones include EMA approval in 2024 and FDA approval in 2025 for chronic hand eczema, addressing limitations ...

Amyloid-beta-targeted monoclonal antibodies probably resulted in little to no difference in cognitive function or in dementia severity.

Intestinal Failure (IF) occurs in patients with an ultrarare congenital enteropathy due to microvillus inclusion ...

Among 5-year survivors in the tebentafusp arm, 44% received tebentafusp as their only therapy. In contrast, 86% of control ...

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...

Although GLP-1 analogs were associated with increased risks for cognitive impairment, they had a larger, protective effect ...